Astellas Pharma, Inc.

Japan

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Jul 24, 2017
Prev close: 1,340
Jul 24, 2017
Market cap:
Market cap(USD):
2,772.22B
25,039.27M
Shares: 2,068.82M

Currency in JPY

Company profile

Market(Ticker): TKS(4503)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Full time employees: 17,202

Business summary

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

In the news

Financial highlights

Mar 2017

  • Local currency
  • US Dollar
Revenue 1,311.66B
Gross profit 955,325M
Operating income 276,520M
Income before tax 283,633M
Net income 218,701M
EBITDA 340,311M
Diluted EPS 103.55
Dividends per share 34
Total assets 1,820.90B
Total liabilities 549,091M
Total equity 1,271.81B
Operating cash flow 237,230M

Currency in JPY

Revenue 12,112.80M
Gross profit 8,822.11M
Operating income 2,553.57M
Income before tax 2,619.25M
Net income 2,019.63M
EBITDA 3,142.66M
Diluted EPS 0.95
Dividends per share 0.31
Total assets 16,341.20M
Total liabilities 4,927.67M
Total equity 11,413.53M
Operating cash flow 2,190.74M

Currency in USD

Valuation measures

Mar 2017

PER 14.13
ROA 12.08%
ROE 17.28%
Operating margin 21.08%
Profit margin 16.67%

Key executive

  • President, CEO & Representative Director: Yoshihiko Hatanaka
  • Chief Financial Officer: Yasumasa Masuda
  • Senior Executive Officer & President-Technology: Mitsunori Matsuda
  • Representative Director & Executive Vice President: Yoshiro Miyokawa
  • Executive Vice President & General Counsel: Linda Friedman

Share holders

  • Asset Management One Co., Ltd.(4.0%)
  • BlackRock Fund Advisors(3.8%)
  • Nomura Asset Management Co., Ltd.(3.8%)
  • Nippon Life Insurance Co.(3.1%)
  • BlackRock Japan Co., Ltd.(2.5%)
  • The Vanguard Group, Inc.(2.2%)
  • Nikko Asset Management Co., Ltd.(1.8%)
  • Daiwa Asset Management Co. Ltd.(1.8%)
  • International Value Advisers LLC(1.8%)
  • T. Rowe Price Associates, Inc.(1.7%)

Address

  • Website: http://www.astellas.com
  • Address: 2-5-1 Nihonbashi-Honcho, Chuo-Ku, Tokyo, 103-8411, Japan
  • Phone: +81.3.3244.3000

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.